Cargando…
Immunoassay-Compatible Inactivation of SARS-CoV-2 in Plasma Samples for Enhanced Handling Safety
[Image: see text] Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) inactivation is an important step toward enhanced biosafety in testing facilities and affords a reduction in the biocontainment level necessary for handling virus-positive biological specimens. Virus inactivation methods...
Autores principales: | Liew, Oi Wah, Fanusi, Felic, Ng, Jessica Yan Xia, Ahidjo, Bintou Ahmadou, Ling, Samantha Shi Min, Lilyanna, Shera, Chong, Jenny Pek Ching, Lim, Angeline Eng Siew, Lim, Wei Zheng, Ravindran, Sindhu, Chu, Justin Jang Hann, Lim, Shir Lynn, Richards, Arthur Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301769/ https://www.ncbi.nlm.nih.gov/pubmed/35903176 http://dx.doi.org/10.1021/acsomega.2c02585 |
Ejemplares similares
-
Phosphodiesterase inhibitors as adjunctive therapies for tuberculosis
por: Ahidjo, Bintou Ahmadou, et al.
Publicado: (2016) -
Epitope-directed monoclonal antibody production using a mixed antigen cocktail facilitates antibody characterization and validation
por: Liew, Oi Wah, et al.
Publicado: (2021) -
Author Correction: Epitope-directed monoclonal antibody production using a mixed antigen cocktail facilitates antibody characterization and validation
por: Liew, Oi Wah, et al.
Publicado: (2021) -
A blood RNA transcriptome signature for COVID-19
por: Kwan, Philip Kam Weng, et al.
Publicado: (2021) -
Signature Optical Cues: Emerging Technologies for Monitoring Plant Health
por: Liew, Oi Wah, et al.
Publicado: (2008)